Stent Fracture and Peri-Stent Contrast Staining After Everolimus-Eluting Stent Implantation　― 5-Year Outcomes ―-Reference-Cited by-同舟云学术

Stent Fracture and Peri-Stent Contrast Staining After Everolimus-Eluting Stent Implantation　― 5-Year Outcomes ―

Published:2017 Issue:10 Volume:81 Page:1514-1521
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Miura Katsuya¹,Tada Takeshi¹,Kuwayama Akinune¹,Shimada Takenobu¹,Ohya Masanobu¹,Amano Hidewo¹,Kubo Shunsuke¹,Hyodo Yusuke¹,Otsuru Suguru¹,Habara Seiji¹,Tanaka Hiroyuki¹,Fuku Yasushi¹,Goto Tsuyoshi¹,Kadota Kazushige¹

Affiliation:

1. Department of Cardiology, Kurashiki Central Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/81/10/81_CJ-17-0236/_pdf

Reference33 articles.

1. 1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315–1323.

2. 2. Morice MC, Serruys PW, Barragan P, Bode C, Van Es GA, Stoll HP, et al. Long-term clinical outcomes with sirolimus-eluting coronary stents: Five-year results of the RAVEL trial. J Am Coll Cardiol 2007; 50: 1299–1304.

3. 3. Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW, et al. Impact of the everolimus-eluting stent on stent thrombosis: A meta-analysis of 13 randomized trials. J Am Coll Cardiol 2011; 58: 1569–1577.

4. 4. Valgimigli M, Sabate M, Kaiser C, Brugaletta S, de la Torre Hernandez JM, Galatius S, et al. Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: Patient level meta-analysis. BMJ 2014; 349: g6427.

5. 5. Gada H, Kirtane AJ, Newman W, Sanz M, Hermiller JB, Mahaffey KW, et al. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: Final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions). JACC Cardiovasc Interv 2013; 6: 1263–1266.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronary Stent Fracture Causing Myocardial Infarction: Case Report and Review of Literature;Reviews in Cardiovascular Medicine;2022-11-16

2. Incidence of coronary drug-eluting stent fracture: A systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2022-08-23

3. Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent;Internal Medicine;2022

4. Relevance of coronary evaginations in bioresorbable vascular scaffolds;Cardiovascular Revascularization Medicine;2019-06

5. Has the Development of Drug-Eluting Stents Ended With Limus-Eluting Stents?;Circulation Journal;2018